Karl-Erik Andersson to Models, Biological
This is a "connection" page, showing publications Karl-Erik Andersson has written about Models, Biological.
Connection Strength
0.549
-
Simonsen U, Comerma-Steffensen S, Andersson KE. Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:63-74.
Score: 0.420
-
Björkelund H, Gedda L, Andersson K. Avoiding false negative results in specificity analysis of protein-protein interactions. J Mol Recognit. 2011 Jan-Feb; 24(1):81-9.
Score: 0.071
-
Vahabi B, Wagg AS, Rosier PFWM, Rademakers KLJ, Denys MA, Pontari M, Lovick T, Valentini FA, Nelson PP, Andersson KE, Fry CH. Can we define and characterize the aging lower urinary tract?-ICI-RS 2015. Neurourol Urodyn. 2017 04; 36(4):854-858.
Score: 0.027
-
Bauer RM, Strittmatter F, Gratzke C, Göttinger J, Schlenker B, Reich O, Stief CG, Hedlund P, Andersson KE, Hennenberg M. Coupling of a1-adrenoceptors to ERK1/2 in the human prostate. Urol Int. 2011; 86(4):427-33.
Score: 0.018
-
Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006 Jul; 148(5):565-78.
Score: 0.013